NAM
SBIO icon

NTV Asset Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

NTV Asset Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$959K Sell
18,318
-716
-4% -$36.4K 0.11% 151
2025
Q4 		$975K Sell
19,034
-502
-3% -$23.2K 0.1% 145
2025
Q3 		$759K Sell
19,536
-800
-4% -$27.5K 0.08% 162
2025
Q2 		$612K Sell
20,336
-6,850
-25% -$196K 0.07% 173
2025
Q1 		$775K Sell
27,186
-2,500
-8% -$79K 0.1% 142
2024
Q4 		$981K Sell
29,686
-1,625
-5% -$61.3K 0.13% 122
2024
Q3 		$1.17M Buy
31,311
+550
+2% +$20.1K 0.16% 112
2024
Q2 		$1.03M Sell
30,761
-800
-3% -$26.8K 0.15% 114
2024
Q1 		$1.13M Sell
31,561
-1,100
-3% -$38.1K 0.17% 108
2023
Q4 		$1.08M Sell
32,661
-12,526
-28% -$336K 0.18% 102
2023
Q3 		$1.23M Sell
45,187
-3,301
-7% -$99.4K 0.22% 92
2023
Q2 		$1.53M Sell
48,488
-300
-0.6% -$9.32K 0.27% 83
2023
Q1 		$1.33M Sell
48,788
-1,630
-3% -$49.2K 0.25% 93
2022
Q4 		$1.53M Sell
50,418
-5,200
-9% -$156K 0.3% 83
2022
Q3 		$1.68M Hold
55,618
– – 0.35% 76
2022
Q2 		$1.54M Sell
55,618
-2,875
-5% -$82K 0.3% 86
2022
Q1 		$1.97M Sell
58,493
-3,815
-6% -$132K 0.33% 82
2021
Q4 		$2.63M Sell
62,308
-4,050
-6% -$181K 0.44% 62
2021
Q3 		$3.02M Sell
66,358
-8,126
-11% -$373K 0.52% 54
2021
Q2 		$3.64M Sell
74,484
-968
-1% -$46.4K 0.64% 49
2021
Q1 		$3.79M Sell
75,452
-1,866
-2% -$103K 0.7% 44
2020
Q4 		$3.96M Buy
77,318
+2,945
+4% +$140K 0.8% 38
2020
Q3 		$3.06M Sell
74,373
-1,055
-1% -$43.5K 0.73% 44
2020
Q2 		$3.15M Buy
75,428
+29,150
+63% +$1.15M 0.82% 35
2020
Q1 		$1.47M Sell
46,278
-1,420
-3% -$54.3K 0.48% 65
2019
Q4 		$2.02M Sell
47,698
-950
-2% -$35.2K 0.51% 58
2019
Q3 		$1.53M Sell
48,648
-900
-2% -$31.6K 0.44% 66
2019
Q2 		$1.79M Buy
49,548
+800
+2% +$27.6K 0.51% 60
2019
Q1 		$1.76M Hold
48,748
– – 0.5% 59
2018
Q4 		$1.37M Sell
48,748
-5,700
-10% -$189K 0.44% 65
2018
Q3 		$2.14M Buy
54,448
+2,998
+6% +$114K 0.58% 56
2018
Q2 		$1.92M Sell
51,450
-400
-0.8% -$14.5K 0.54% 59
2018
Q1 		$1.77M Buy
51,850
+37,050
+250% +$1.3M 0.5% 62
2017
Q4 		$485K Sell
14,800
-2,000
-12% -$62.6K 0.14% 130
2017
Q3 		$524K Buy
16,800
+1,700
+11% +$49.9K 0.15% 125
2017
Q2 		$420K Buy
+15,100
New +$392K 0.13% 131

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return

NTV Asset Management's SBIO Position: Q1 2026 in Review

NTV Asset Management reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 3.8% in Q1 2026, selling an estimated $36.4K and leaving 18,318 shares worth $959K. The position accounts for 0.11% of the portfolio, ranked #151.

NTV Asset Management first reported a position in SBIO in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.96M in Q4 2020. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • NTV Asset Management held 18,318 shares of ALPS Medical Breakthroughs ETF worth $959K as of Q1 2026.
  • NTV Asset Management sold 716 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $36.4K.
  • ALPS Medical Breakthroughs ETF made up 0.11% of NTV Asset Management's portfolio in Q1 2026, its #151 holding.
  • NTV Asset Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2017 and has held it in 36 quarters since.
  • NTV Asset Management's ALPS Medical Breakthroughs ETF position peaked at $3.96M in Q4 2020.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.